In a modeling analysis, initiating direct acting or nonvitamin K oral anticoagulants (DOAC/NOAC) in patients with device-detected subclinical atrial fibrillation (AF) provided a net gain of ...
LOS ANGELES — Direct oral anticoagulants (DOACs) in patients with a recent intracerebral hemorrhage (ICH) and atrial fibrillation (AF) may have an overall benefit by reducing ischemic stroke, new ...
Please provide your email address to receive an email when new articles are posted on . Many high-risk groups of patients with atrial fibrillation can use direct oral anticoagulants safely. Patients ...
NEW YORK, NY—Patients undergoing TAVI who have an indication for oral anticoagulation are less likely to die over 5 years of follow-up if they’re discharged on a direct oral anticoagulant (DOAC) ...
Among patients with atrial fibrillation (AF) who have survived an intracerebral hemorrhage (ICH), taking a direct oral anticoagulant (DOAC) markedly lowers the risk ischemic stroke but at the cost of ...
A large meta-analysis found that initiating DOACs without delay in certain stroke patients reduced future stroke events without increasing symptomatic intracerebral hemorrhage. The report included the ...
LOS ANGELES -- In the PRESTIGE-AF trial, survivors of intracerebral hemorrhage (ICH) had good protection against future ischemic events using direct oral anticoagulants (DOACs) -- though, as feared, ...
Sponsored by: Diagnostica Stago, Inc. Direct oral anticoagulants (DOACs), such as direct thrombin inhibitors and direct factor Xa inhibitors, are increasingly prescribed in various clinical scenarios ...
Patients with atrial fibrillation (Afib) who took low doses of blood-thinning medications known as direct oral anticoagulants (DOACs) experienced more bleeding episodes during the first three months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results